Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

VT3989 is safe and well tolerated in patients with advanced malignant mesothelioma and NF2m cancers

Dr Timothy Yap - The University of Texas MD Anderson Cancer Center, Houston, USA
VT3989 is safe and well tolerated in patients with advanced malignant mesothelioma and NF2m cancers ( Dr Timothy Yap - The University of Texas MD Anderson Cancer Center, Houston, USA )
25 Apr 2023

Childhood cancer: The surprising scientific facts

Dr Mlis Ratha - Calmette Hospital, Phnom Penh, Cambodia
Childhood cancer: The surprising scientific facts ( Dr Mlis Ratha - Calmette Hospital, Phnom Penh, Cambodia )
25 Apr 2023

Current and future status of cancer care in Calmette Hospital

Dr Rath Beauta - Calmette Hospital, Phnom Penh, Cambodia
Current and future status of cancer care in Calmette Hospital ( Dr Rath Beauta - Calmette Hospital, Phnom Penh, Cambodia )
25 Apr 2023

Combination of camonsertib plus PARPi shows clinical activity in DDR-aberrant tumours

Dr Timothy Yap - The University of Texas MD Anderson Cancer Center, Houston, USA
Combination of camonsertib plus PARPi shows clinical activity in DDR-aberrant tumours ( Dr Timothy Yap - The University of Texas MD Anderson Cancer Center, Houston, USA )
25 Apr 2023

Durable effect of imatinib and metronomic chemotherapy with capecitabine in pancreatic carcinoma

Dr Sana Al-Sukhun - Al Hyatt Oncology Practice, Amman, Jordan
Durable effect of imatinib and metronomic chemotherapy with capecitabine in pancreatic carcinoma ( Dr Sana Al-Sukhun - Al Hyatt Oncology Practice, Amman, Jordan )
21 Apr 2023

The importance of providing post-treatment care to cancer survivors

Dr Lidia Schapira - Stanford Medicine, California, USA
The importance of providing post-treatment care to cancer survivors ( Dr Lidia Schapira - Stanford Medicine, California, USA )
20 Apr 2023

Cancer Survivorship

Dr Lidia Schapira - Stanford Medicine, California, USA
Cancer Survivorship ( Dr Lidia Schapira - Stanford Medicine, California, USA )
20 Apr 2023

Cancer Care in Older Adults and Special Population

Dr Don Dizon - Rhode Island Hospital, Rhode Island, USA
Cancer Care in Older Adults and Special Population ( Dr Don Dizon - Rhode Island Hospital, Rhode Island, USA )
20 Apr 2023

The clinical impact of the Choosing Wisely project

Dr Frederic Ting - Riverside Medical Center, Bacolod, Philippines
The clinical impact of the Choosing Wisely project ( Dr Frederic Ting - Riverside Medical Center, Bacolod, Philippines )
20 Apr 2023

Why tumour markers are not recommended as screening tests

Dr Frederic Ting - Riverside Medical Center, Bacolod, Philippines
Why tumour markers are not recommended as screening tests ( Dr Frederic Ting - Riverside Medical Center, Bacolod, Philippines )
20 Apr 2023

ALLO-316 demonstrates encouraging anti-tumour activity for patients with advanced or metastatic ccRCC

Dr Samer Srour - The University of Texas MD Anderson Cancer Center, Houston, USA
ALLO-316 demonstrates encouraging anti-tumour activity for patients with advanced or metastatic ccRCC ( Dr Samer Srour - The University of Texas MD Anderson Cancer Center, Houston, USA )
20 Apr 2023

Addition of Salmonella-IL2 to FOLFIRINOX for metastatic stage 4 pancreatic cancer nearly doubles median survival

Prof Daniel Saltzman - University of Minnesota, Minneapolis, USA
Addition of Salmonella-IL2 to FOLFIRINOX for metastatic stage 4 pancreatic cancer nearly doubles median survival ( Prof Daniel Saltzman - University of Minnesota, Minneapolis, USA )
20 Apr 2023